<DOC>
	<DOCNO>NCT01655095</DOCNO>
	<brief_summary>Colon capsule endoscopy technology develop noninvasive method examine large bowel . The big limitation use find bowel preparation clean colon adequately good visualization mucosa also help propel capsule colon . Most study conduct Europe use bowel preparation medication approve use North America . The purpose study compare combination polyethylene glycol ( PEG ) prucalopride Picosalax prucalopride determine regime give good colon cleanse colon capsule . Both PEG Picosalax bowel preparation use routinely colonoscopy Canada . Prucalopride new medication recently approve use Canada improve intestinal motility help colon capsule transit . Patients refer colonoscopy enrol study randomize one bowel preparation regime . They undergo split-dose bowel preparation either PEG Picosalax , routine colonoscopy . As part standard bowel preparation , patient randomize Picosalax group take dulcolax three night test two night test . The evening test patient take either PEG 2L one sachet Picosalax . The following morning take another dose either PEG ( 2 Liter container ) one sachet Picosalax . They ingest colon capsule dose Prucalopride morning . After 7 hour return endoscopy unit undergo colonoscopy , standard care examination colon . The image colon capsule review quality bowel preparation grade use previously validate scale . It hypothesize Picosalax prucalopride regime give good cleanse colon PEG prucalopride less turbid fluid colon allow good view mucosa . Polyp detection abnormality mucosa detect colon capsule also compare polyps abnormality detect time colonoscopy .</brief_summary>
	<brief_title>Improving Bowel Preparation Colon Capsule</brief_title>
	<detailed_description />
	<mesh_term>Bisacodyl</mesh_term>
	<criteria>Male female patient age 18 75 Patients refer colonoscopy Symptoms dysphagia Bowel obstruction ileus Known stricture fistula Inflammatory bowel disease Previous small large bowel surgery Severe gastroparesis motility disorder Renal impairment ( GFR &lt; 55 within 3 month study ) Congestive heart failure ( NYHA III IV ) Ischemic heart disease Cirrhosis severe hepatic dysfunction ( ascites lab result INR &gt; 2 ) History serious arrhythmia Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Colon capsule</keyword>
	<keyword>Picosalax</keyword>
	<keyword>PEG</keyword>
	<keyword>Prucalopride</keyword>
</DOC>